Antiplatelet therapy and adverse outcomes in high cardiovascular risk elderly patients: a sex and gender focused analysis from REPOSI study

Back

ESC Premium Access

Antiplatelet therapy and adverse outcomes in high cardiovascular risk elderly patients: a sex and gender focused analysis from REPOSI study

Session: Remaining in the spotlight: antiplatelet agents

Topic: Drug therapy

Speaker: Associate Professor M. Proietti (Milan, IT)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)

11 presentations

1 follower

6 more presentations in this session

Stroke rate after twelve versus 30 month dual antiplatelet therapy in percutaneous coronary intervention patients using korean national health insurance service (nhis)

Speaker: Ms S. Kang (Busan, KR)

Access

Abstract

Slides

Temporal trends in the use of antiplatelet therapy in patients with acute coronary syndromes

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Access

Abstract

Slides

The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy.

Speaker: Mr W. Liu (Beijing, CN)

Access

Abstract

Slides

Efficacy and safety of perioperative aspirin therapy in non-cardiac surgery: a systematic review and comprehensive meta-analysis of randomized controlled trials

Speaker: Mr G. Wolff (Ibbenbüren, DE)

Access

Abstract

Slides

Anti-platelet effect of intravenous P2Y12 receptor inhibitor cangrelor is not influenced by reticulated platelets

Speaker: Doctor C. Stratz (Bad Krozingen, DE)

Access

Abstract

Slides

Access the full session

Remaining in the spotlight: antiplatelet agents

Speakers: Associate Professor M. Proietti, Ms S. Kang, Doctor M. Esteve Pastor, Mr W. Liu, Mr G. Wolff...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources